Application and interpretation of FISH in biomarker studies

被引：14

作者：

Bayani, Jane

Squire, Jeremy A.

机构：

[1] Princess Margaret Hosp, Univ Hlth Network, Div Appl Mol Oncol, Toronto, ON M5G 2M9, Canada

[2] Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Univ Hlth Network,Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada

[3] Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Univ Hlth Network,Dept Med Biophys, Toronto, ON M5G 2M9, Canada

来源：

CANCER LETTERS | 2007年 / 249卷 / 01期

关键词：

chromosomes; cancer genes; arrays;

D O I：

10.1016/j.canlet.2006.12.030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Emerging genomic and proteomic data is creating new opportunities to identify novel biomarkers that will have pathway-specific therapeutic impact on cancer progression. Molecular cytogenetic and fluorescence in situ hybridization (FISH) methods have been primarily used in discovery genetic research laboratories until recently. New automated analytical platforms based on FISH technologies and tissue microarray methods are providing a rapid means to determine the impact of consistent genomic aberrations in clinical trials, and in studies designed to investigate differential chemotherapeutic response. (C) 2007 Elsevier Ireland Ltd. All rights reserved.

引用

收藏

页码：97 / 109

页数：13

相关论文

共 106 条

[11] Tissue microarrays: bridging the gap between research and the clinic [J].

Braunschweig, T ;

Chung, JY ;

Hewitt, SM .

EXPERT REVIEW OF PROTEOMICS, 2005, 2 (03) :325-336

[12] Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis [J].

Breivik, J ;

Gaudernack, G .

SEMINARS IN CANCER BIOLOGY, 1999, 9 (04) :245-254

[13] Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].

Brunet, A ;

Bonni, A ;

Zigmond, MJ ;

Lin, MZ ;

Juo, P ;

Hu, LS ;

Anderson, MJ ;

Arden, KC ;

Blenis, J ;

Greenberg, ME .

CELL, 1999, 96 (06) :857-868

[14] Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer [J].

Cappuzzo, F ;

Hirsch, FR ;

Rossi, E ;

Bartolini, S ;

Ceresoli, GL ;

Bemis, L ;

Haney, J ;

Witta, S ;

Danenberg, K ;

Domenichini, I ;

Ludovini, V ;

Magrini, E ;

Gregorc, V ;

Doglioni, C ;

Sidoni, A ;

Tonato, M ;

Franklin, WA ;

Crino, L ;

Bunn, PA ;

Varella-Garcia, M .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (09) :643-655

[15] Regulation of cell death protease caspase-9 by phosphorylation [J].

Cardone, MH ;

Roy, N ;

Stennicke, HR ;

Salvesen, GS ;

Franke, TF ;

Stanbridge, E ;

Frisch, S ;

Reed, JC .

SCIENCE, 1998, 282 (5392) :1318-1321

[16] Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis [J].

Cully, M ;

You, H ;

Levine, AJ ;

Mak, TW .

NATURE REVIEWS CANCER, 2006, 6 (03) :184-192

[17]

DAO DD, 1994, LEUKEMIA, V8, P1280

[18] Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].

Datta, SR ;

Dudek, H ;

Tao, X ;

Masters, S ;

Fu, HA ;

Gotoh, Y ;

Greenberg, ME .

CELL, 1997, 91 (02) :231-241

[19] Pten is essential for embryonic development and tumour suppression [J].

Di Cristofano, A ;

Pesce, B ;

Cordon-Cardo, C ;

Pandolfi, PP .

NATURE GENETICS, 1998, 19 (04) :348-355

[20]

Duesberg P, 2006, CONTRIB MICROBIOL, V13, P16, DOI 10.1159/000092963

← 1 2 3 4 5 6 7 8 9 10 →